Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in MAZE — Maze Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in MAZE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$706,521
-$48,713 QoQ
Shares Held
23,677
-6.4% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MAZE Over Time

Shares Held

Position Value (USD)

Derivatives in MAZE

reported options exposure · as of Jun 30, 2026
CallValue
$954,880
CallShares
32,000
PutValue
$969,800
PutShares
32,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. MAZE ranks #142 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MAZE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $954,880 32,000
2026-06-30 $969,800 32,500
2026-06-30 $706,521 23,677
2026-03-31 $755,234 25,301
2026-03-31 $1,265,640 42,400
2026-03-31 $1,799,955 60,300
2025-12-31 $803,742 19,400
2025-09-30 $419,158 16,165
2025-06-30 $129,657 10,567
2025-03-31 $116,794 10,608